国产西罗莫司药物洗脱支架治疗冠心病331例的疗效及安全性Clinical application of domestic rapamycin-eluting stents in coronary heart disease patients
薛玉增,高航,任海舟,刘淑琴,孔敬博,孔祥泉,霍勇
摘要(Abstract)：
目的探讨国产西罗莫司药物洗脱支架治疗冠心病的安全性与有效性。方法对331例冠心病患者采用经股动脉途径冠状动脉造影及常规方法行国产药物洗脱支架置入术,记录住院期间主要不良心脏事件(MACE)发生情况,术后1年随访,6~9个月行冠状动脉造影复查。结果331例冠心病患者共置入支架597只,均成功置入病变处;1例心源性休克行急诊经皮冠状动脉介入治疗(PC I)支架置入后3 h死于泵衰竭,1例发生血管破裂转外科行急诊冠状动脉旁路移植术,3例术后出现非Q波型心肌梗死,住院期间MACE发生率为1.5%。301例患者随访12.3±3.2个月,2例死亡,2例支架内血栓形成,1例非致死性心肌梗死,16例再次心绞痛发作,5例再次靶病变血运重建术,总的MACE发生率为4.3%;110例患者6~9个月行冠状动脉造影复查,6例支架内再狭窄,再狭窄率5.5%。结论国产西罗莫司药物洗脱支架治疗冠心病患者安全、有效,有较好的近、中期疗效和较高的效益/价格比,尤其适用于经济欠发达地区,可使更多冠心病患者受益;但其远期效果有待进一步研究。
关键词(KeyWords)： 支架;西罗莫司;冠状动脉疾病
基金项目(Foundation):
作者(Author): 薛玉增,高航,任海舟,刘淑琴,孔敬博,孔祥泉,霍勇
参考文献(References)：
- [1]Morice MC,Serruys PW,Sousa JE,et al..A randomized compari-son of a sirolimus-eluting stent with a standard stent for coronaryrevascularization.N Engl J Med,2002,346:1773-1780.
- [2]Moses JW,Leon MB,Pomma JJ,et al.Sirolimus-eluting stentsversus standard stents in patients with stenosis in a native coro-nary artery.N Engl J Med,2003,349:1315-1323.
- [3]Jeremias A,Sylvia B,Bridges J,et al.Stent thrombosis after suc-cessful Sirolimus-eluting stents implantation.Circulation,2004,109:1930-1932.
- [4]Sino-SIRIUS研究组.国人应用西罗莫司药物洗脱支架预防再狭窄的初步经验.中华心血管病杂志,2003,31:814-817.
- [5]Lemos PA,Serruys PW,van Domburg RT,et al.Unrestricted u-tilization of sirolimus-eluting stents compared with conventionalbare stent implantation in the“real world”:the Rapamycin-Elu-ting stent Evaluated At Rotterdam Cardiology Hospital(RE-SEARCH)registry.Circulation,2004,109:190-195.
- [6]调查协作组.中国多中心药物洗脱支架急性或亚急性血栓的调查.中国介入心脏病学杂志,2005,13:131-134.
- [7]McFadden EP,Stabile E,Regar E,et al.Late thrombosis indrug-eluting coronary stents after discontinuation of antiplatelettherapy.Lancet,2004,364:1519-1521.
- [8]Moses JW,Mehran R,Nikolsky E,et al.Outcomes with the pa-clitaxel-eluting stent in patients with acute coronary syndromes:analysis from the TAXUS-IV trial.J Am Coll Cardiol,2005,45:1165-1171.
- [9]Berenguer A,Mainar V,Bordes P,et al.Incidence and predic-tors of restenosis after sirolimus-eluting stent implantation in high-risk patients.Am Heart J,2005,150:536-542.